Alcon Net Profit Margin 2019-2022 | ALC
Current and historical net profit margin for Alcon (ALC) from 2019 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue. Alcon net profit margin for the three months ending March 31, 2022 was .
| Alcon Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2022-03-31 |
$8.55B |
$0.46B |
5.38% |
| 2021-12-31 |
$8.29B |
$0.38B |
4.54% |
| 2021-09-30 |
$8.08B |
$0.33B |
4.11% |
| 2021-06-30 |
$7.82B |
$0.18B |
2.34% |
| 2021-03-31 |
$6.92B |
$-0.39B |
-5.63% |
| 2020-12-31 |
$6.83B |
$-0.53B |
-7.77% |
| 2020-09-30 |
$6.81B |
$-0.72B |
-10.53% |
| 2020-06-30 |
$6.84B |
$-0.64B |
-9.30% |
| 2020-03-31 |
$7.53B |
$-0.60B |
-8.03% |
| 2019-12-31 |
$7.51B |
$-0.66B |
-8.74% |
| 2019-06-30 |
$5.49B |
$-0.71B |
-12.86% |
| 2019-03-31 |
$5.41B |
$-0.30B |
-5.57% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$35.080B |
$8.291B |
|
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
|
